Trulieve Cannabis Corp.
TRLV NYSE
SEC CIK 1754195
Follow Trulieve Cannabis Corp.
Weekly email: filings, results
Revenue, last quarter
$230.2M
−20.1% vs same quarter last year
Net income
$774K
+102.7% vs same quarter last year
EPS, diluted
$0.00
+100% vs same quarter last year
Operating cash flow
$74.4M
−2.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.2B | −$116.4M |
| FY24 | $1.2B | −$155.1M |
| FY23 | $1.1B | −$526.8M |
| FY22 | $1.2B | −$246.1M |
| FY21 | $931.9M | $18M |
| FY20 | $521.5M | $63M |
| FY19 | $252.8M | $53.1M |
| FY18 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 60.2% | 12.1% | −9.9% |
| FY24 | 60.3% | 8.2% | −13.1% |
| FY23 | 52.1% | −19.6% | −46.7% |
| FY22 | 56.6% | 4.1% | −20.2% |
| FY21 | 60.8% | 21.9% | 1.9% |
| FY20 | 74.1% | 41.9% | 12.1% |
| FY19 | 75.9% | 44.8% | 21% |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $228.6M |
| FY24 | $148.9M |
| FY23 | $161.6M |
| FY22 | −$141.7M |
| FY21 | −$263M |
| FY20 | −$298K |
| FY19 | −$52.8M |
| FY18 | - |
- Trulieve Cannabis Corp.
- Healthcare median
Show the numbers
| Year | Trulieve Cannabis Corp. | Healthcare median |
|---|---|---|
| FY25 | −9.9% | −30.6% |
| FY24 | −13.1% | −47% |
| FY23 | −46.7% | −58% |
| FY22 | −20.2% | −80.4% |
| FY21 | 1.9% | −71.9% |
| FY20 | 12.1% | −62.2% |
| FY19 | 21% | −46.3% |
| FY18 | - | −49.6% |